首页 | 本学科首页   官方微博 | 高级检索  
     

噻吗洛尔外敷联合32P敷贴治疗婴幼儿血管瘤的疗效观察
引用本文:李宗良,马荣欣,魏雁,冯艳丽,左江华. 噻吗洛尔外敷联合32P敷贴治疗婴幼儿血管瘤的疗效观察[J]. 临床小儿外科杂志, 2021, 0(4): 354-358
作者姓名:李宗良  马荣欣  魏雁  冯艳丽  左江华
作者单位:河北省邢台市人民医院核医学科;河北省邢台市人民医院药剂科;河北省邢台市人民医院检验科
基金项目:河北省青年科技课题计划项目(编号:20201580)。
摘    要:目的观察噻吗洛尔外敷联合32P敷贴治疗婴幼儿血管瘤的临床疗效。方法选取河北省邢台市人民医院120例婴幼儿血管瘤患者作为研究对象,按照随机数字表法分成观察组和对照组,每组60例。观察组第一疗程采用32P敷贴治疗,之后改为单独噻吗洛尔外敷治疗;对照组全程采用32P敷贴治疗,最多给予3个疗程的治疗。对两组临床总有效率和副作用发生情况进行比较分析。结果两组患者的年龄、性别、血管瘤面积和部位差异无统计学意义(P>0.05),具有可比性。观察组治愈26例,总有效率为93.33%(56/60);对照组治愈29例,总有效率为96.67%(58/60),两组总有效率比较差异无统计学意义(χ2=0.702,P>0.05)。治疗后第4个月,观察组的治愈率为26.67%,低于对照组的45.00%,差异有统计学意义(χ2=4.385,P=0.036);治疗后第6个月,两组治愈率无差异(χ2=0.302,P=0.583)。观察组的副作用发生率低于对照组(16.67%vs.45.00%),差异有统计学意义(P<0.01)。结论噻吗洛尔外敷联合32P敷贴治疗婴幼儿血管瘤疗效确定、临床效果满意,能有效降低色素脱失和色素沉着等副作用的发生率。

关 键 词:血管瘤/治疗  噻吗洛尔  32P敷贴  治疗结果  婴幼儿

Efficacy of timolol plus 32P applicator brachytherapy for infantile hemangioma
Li Zongliang,Ma Rongxin,Wei Yan,Feng Yanli,Zuo Jianghua. Efficacy of timolol plus 32P applicator brachytherapy for infantile hemangioma[J]. Journal of Clinical Pediatric Surgery, 2021, 0(4): 354-358
Authors:Li Zongliang  Ma Rongxin  Wei Yan  Feng Yanli  Zuo Jianghua
Affiliation:(Department of Nuclear Medicine,Municipal People's Hospital,Xingtai 054001,China;Department of Pharmacy,Municipal People's Hospital,Xingtai 054001,China;Department of Clinical Laboratory,Municipal People's Hospital,Xingtai 054001,China)
Abstract:Objective To explore the clinical efficacy of timolol plus 32P applicator brachytherapy for infantile hemangioma(IH).Methods A total of 120 IH children were selected as subjects.They were randomly divided into observation and control groups(n=60 each).The observation group received an initial course of 32P applicator and a subsequent therapy of timolol alone.The control group received a whole course of 32P applicator for at most 3 sessions.The total effective rate and side effects of two groups were compared.Results No significant inter-group difference existed in age,gender,hemangioma area or site(P>0.05).In observation group,26 cases were cured with a total effective rate of 93.33%(56/60)while 29 cases were cured with a total effective rate of 96.67%(58/60)in control group.No inter-group difference of statistical significance existed in total effective rate(χ2=0.702,P>0.05).The incidence of side effects was significantly lower in observation group than that in control group(P<0.01).At Month 4 of treatment,the cure rate of observation group was lower than that of control group(χ2=4.385,P=0.036)while no inter-group difference in cure rate at Month 6(χ2=0.302,P=0.583).The incidence of side effects was significantly lower in observation group than that in control group.And the difference was statistically significant(P<0.01).Conclusion With a definite and satisfactory efficacy for IH,a combination of timolol and 32P application may effectively reduce the incidence of such side effects as depigmentation and pigmentation.
Keywords:Hemangioma/TH  Timolol  32P Applicator Brachytherapy  Treatment Outcome  Infant
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号